Human leukocyte antigen variation and Parkinson's disease

Parkinsonism and Related Disorders

Volumn 17, Issue 5, 2011, Pages 376-378

  Puschmann, Andreas ^a,b   Verbeeck, Christophe ^a   Heckman, Michael G ^c   Soto Ortolaza, Alexandra I ^a   Lynch, Timothy ^d,e   Jasinska Myga, Barbara ^f   Opala, Grzegorz ^f   Krygowska Wajs, Anna ^g   Barcikowska, Maria ^h   Uitti, Ryan J ^c   Wszolek, Zbigniew K ^c   Ross, Owen A ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b LUND UNIVERSITY   (Sweden)

^c MAYO CLINIC   (United States)

^d MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^e UNIVERSITY COLLEGE DUBLIN   (Ireland)

^f MEDICAL UNIVERSITY OF SILESIA   (Poland)

^g JAGIELLONIAN UNIVERSITY   (Poland)

^h MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Association studies; Genetics; HLA; HLA DRA; Human leukocyte antigen; Immune system; Parkinson's disease

Indexed keywords

HLA ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENIC VARIATION; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HLA-DR ANTIGENS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 79957935283     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2011.03.008     Document Type: Article

References (12)

1. Ross O.A., Farrer M.J. Parkinson disease: Parkinson disease-moving beyond association. Nat Rev Neurol 2010 Jun, 6(6):305-307.
2. Hamza T.H., Zabetian C.P., Tenesa A., Laederach A., Montimurro J., Yearout D., et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet 2010 Sep, 42(9):781-785.
3. McGeer P.L., McGeer E.G. Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism Relat Disord 2004, 10:S3-S7.
4. Lampe J.B., Gossrau G., Herting B., Kempe A., Sommer U., Fussel M., et al. HLA typing and Parkinson's disease. Eur Neurol 2003, 50(2):64-68.
5. Saiki M., Baker A., Williams-Gray C.H., Foltynie T., Goodman R.S., Taylor C.J., et al. Association of the human leucocyte antigen region with susceptibility to Parkinson's disease. J Neurol Neurosurg Psychiatr 2010 Aug, 81(8):890-891.
6. Caruso C., Candore G., Romano G.C., Lio D., Bonafe M., Valensin S., et al. Immunogenetics of longevity. Is major histocompatibility complex polymorphism relevant to the control of human longevity? A review of literature data. Mech Ageing Dev 2001 Apr 30, 122(5):445-462.
7. Ouchi Y., Yagi S., Yokokura M., Sakamoto M. Neuroinflammation in the living brain of Parkinson's disease. Parkinsonism Relat Disord 2009 Dec, 15(Suppl. 3):S200-S204.
8. McGeer P.L., Itagaki S., Boyes B.E., McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988 Aug, 38(8):1285-1291.
9. Chen H., Zhang S.M., Hernan M.A., Schwarzschild M.A., Willett W.C., Colditz G.A., et al. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch Neurol 2003 Aug, 60(8):1059-1064.
10. Gagne J.J., Power M.C. Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis. Neurology 2010 Mar 23, 74(12):995-1002.
11. Ross O.A., Hinkle K.M., Rea I.M. Cytokine polymorphisms and Immunosenescence. Handbook on Immunosenescence 2009, 631-658. Springer Pub. F. al (Ed.).
12. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 2011 Feb 19, 377(9766):641-649. International Parkinson Disease Genetics Consortium.